Nesvacumab Uses, Dosage, Side Effects and more
Nesvacumab is under investigation in clinical trial NCT01997164 (Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular (Wet) Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME)).
| Attribute | Details |
|---|---|
| Trade Name | Nesvacumab |
| Generic | Nesvacumab |
| Nesvacumab Other Names | Nesvacumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Innovators Monograph
Search Medicines
